Compare Neurocrine Biosciences Inc (NBIX) vs Toyota Motor Corp (TM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Toyota Motor Corp — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while Toyota Motor Corp trades at $180.4 (market cap $212.22B). The key difference: Toyota Motor Corp is far larger — about 12.2× Neurocrine Biosciences Inc's market cap, and Toyota Motor Corp pays a 3.51% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| NBIX | TM | |
|---|---|---|
Market Cap | $17.40B | $212.22B |
Sector | Health | Consumer Cyclical |
52-Week High | $180.55 | $248.29 |
52-Week Low | $123.10 | $166.50 |
Enterprise Value | $16.49B | $376.42B |
Dividend Yield | — | 3.51% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Toyota Motor Corp
Founded in 1937, Toyota is one of the world's largest automakers with 10.38 million units sold at retail in fiscal 2022 across its light vehicle brands. Brands include Toyota, Lexus, Daihatsu, and truck maker Hino.
Read more on TM →
